dihydrotestosterone has been researched along with Lower Urinary Tract Symptom in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (60.00) | 24.3611 |
| 2020's | 2 (40.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gahan, JC; Henry, GH; Hutchinson, RC; Joseph, DB; Malewska, A; Mauck, RJ; Mohler, JL; Reese, JC; Roehrborn, CG; Strand, DW | 1 |
| Burke, S; Case, T; Cates, JM; Forbes, C; Jin, R; Kim, HH; Mantione, KM; Matusik, RJ; Miller, NL; Mohler, JL; Porter, NA; Strand, D; Wages, P | 1 |
| Culig, Z; Madersbacher, S; Sampson, N | 1 |
| Given, L; Harisaran, V; Kacker, R; Miner, M; Morgentaler, A; Rittmaster, R | 1 |
| Izumi, K; Kitagawa, Y; Koh, E; Miyagi, T; Mizokami, A; Nakashima, T; Namiki, M; Shigehara, K; Shimamura, M | 1 |
1 review(s) available for dihydrotestosterone and Lower Urinary Tract Symptom
| Article | Year |
|---|---|
Pathophysiology of Benign Prostatic Hyperplasia and Benign Prostatic Enlargement: A Mini-Review.
Topics: 3-Oxo-5-alpha-Steroid 4-Dehydrogenase; 5-alpha Reductase Inhibitors; Aging; Diabetes Mellitus; Dihydrotestosterone; Dutasteride; Dyslipidemias; Finasteride; Humans; Inflammation; Lower Urinary Tract Symptoms; Male; Metabolic Syndrome; Prostatic Hyperplasia; Receptors, Androgen | 2019 |
2 trial(s) available for dihydrotestosterone and Lower Urinary Tract Symptom
| Article | Year |
|---|---|
Dutasteride in men receiving testosterone therapy: a randomised, double-blind study.
Topics: 5-alpha Reductase Inhibitors; Aged; Aged, 80 and over; Azasteroids; Dihydrotestosterone; Dose-Response Relationship, Drug; Double-Blind Method; Dutasteride; Erectile Dysfunction; Hormone Replacement Therapy; Humans; Longitudinal Studies; Lower Urinary Tract Symptoms; Male; Middle Aged; Organ Size; Prostate; Prostate-Specific Antigen; Prostatic Hyperplasia; Testosterone; Treatment Outcome | 2015 |
Effects of dutasteride on lower urinary tract symptoms: a prospective analysis based on changes in testosterone/dihydrotestosterone levels and total prostatic volume reduction.
Topics: 5-alpha Reductase Inhibitors; Dihydrotestosterone; Dutasteride; Humans; Lower Urinary Tract Symptoms; Male; Organ Size; Prospective Studies; Prostate; Prostatic Hyperplasia; Testosterone | 2016 |
2 other study(ies) available for dihydrotestosterone and Lower Urinary Tract Symptom
| Article | Year |
|---|---|
5-Alpha reductase inhibitors induce a prostate luminal to club cell transition in human benign prostatic hyperplasia.
Topics: 5-alpha Reductase Inhibitors; Atrophy; Dihydrotestosterone; Humans; Lower Urinary Tract Symptoms; Male; Prostate; Prostatic Hyperplasia | 2022 |
Glucocorticoids are induced while dihydrotestosterone levels are suppressed in 5-alpha reductase inhibitor treated human benign prostate hyperplasia patients.
Topics: 3-Oxo-5-alpha-Steroid 4-Dehydrogenase; 5-alpha Reductase Inhibitors; Dihydrotestosterone; Glucocorticoids; Humans; Hyperplasia; Lower Urinary Tract Symptoms; Male; Membrane Proteins; Prostate; Prostatic Hyperplasia | 2022 |